ERCC1 mRNA Expression as a Postoperative Prognostic Marker in Extrahepatic Bile Duct Cancer

被引：1
|
作者：
Shuichiro Uemura
Hidekazu Kuramochi
Ryota Higuchi
Go Nakajima
Masakazu Yamamoto
机构：
[1] Tokyo Women’s Medical University,Department of Surgery, Institute of Gastroenterology
[2] Tokyo Women’s Medical University,Department of Chemotherapy and Palliative Care
来源：
Annals of Surgical Oncology | 2014年 / 21卷
关键词：
Overall Survival; Epidermal Growth Factor Receptor; Curative Resection; Biliary Tract Cancer; Bile Duct Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：627 / 633
页数：6
相关论文
共 50 条
  • [21] Relationship of ERCC1 genotype variant with mRNA expression and ERCC1 protein levels in advanced urothelial carcinoma (UC)
    Guancial, Elizabeth A.
    Werner, Lillian
    Bellmunt, Joaquim
    Nikitas, Nikitas
    Stack, Edward C.
    Lis, Rosina
    Signoretti, Sabina
    Loda, Massimo
    Regan, Meredith M.
    Park, Rachel S.
    O'Brien, Robert
    Berman, David M.
    Bamias, Aristotelis
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [22] Prognostic implication of ERCC1 protein expression in resected oropharynx and oral cavity cancer
    An, Ho Jung
    Jo, Heejoon
    Jung, Chan Kwon
    Kang, Jin Hyoung
    Kim, Min Sik
    Sun, Dong-Il
    Cho, Kwang Jae
    Cho, Jung-Hae
    Won, Hye Sung
    Sun, Der Sheng
    Ko, Yoon Ho
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (08) : 949 - 955
  • [23] Ceruloplasmin as a prognostic marker in patients with bile duct cancer
    Han, In Woong
    Jang, Jin-Young
    Kwon, Wooil
    Park, Taesung
    Kim, Yongkang
    Lee, Kyoung Bun
    Kim, Sun-Whe
    ONCOTARGET, 2017, 8 (17) : 29028 - 29037
  • [24] Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
    Bellmunt, J.
    Paz-Ares, L.
    Cuello, M.
    Cecere, F. L.
    Albiol, S.
    Guillem, V.
    Gallardo, E.
    Carles, J.
    Mendez, P.
    de la Cruz, J. J.
    Taron, M.
    Rosell, R.
    Baselga, J.
    ANNALS OF ONCOLOGY, 2007, 18 (03) : 522 - 528
  • [25] ERCC1 expression in triple negative breast cancer
    Ozkan, C.
    Gumuskaya, B.
    Yaman, S.
    Aksoy, S.
    Guler, G.
    Altundag, K.
    JOURNAL OF BUON, 2012, 17 (02): : 271 - 276
  • [26] Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer
    Kato, Yuichiro
    Takahashi, Shinichiro
    Gotohda, Naoto
    Konishi, Masaru
    JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (08) : 1435 - 1443
  • [27] ERCC1 expression of small cell lung cancer
    Hennemann, Marluce
    Sostruznik, Maria H.
    Gaiger, Ana
    Barrios, Carlos H.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S807 - S807
  • [28] Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer
    Yuichiro Kato
    Shinichiro Takahashi
    Naoto Gotohda
    Masaru Konishi
    Journal of Gastrointestinal Surgery, 2016, 20 : 1435 - 1443
  • [29] Prognostic Impact of ERCC1 Gene Polymorphisms in Gastric Cancer
    Metzger, Ralf
    Warnecke-Eberz, Ute
    Bollschweiler, Elfriede
    Brabender, Jan
    Vallbohmer, Daniel
    Hoelscher, Amulf H.
    GASTROENTEROLOGY, 2009, 136 (05) : A920 - A920
  • [30] Analysis of patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: Implications for postoperative adjuvant radiotherapy
    Kim, Jae-Sung
    Koo, Tae Ryool
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345